Patent · US Active

GLP-2 mimetibodies, polypeptides, compositions, methods and uses

US7812121B2 · kind B2 · utility

1Cited by
2References
10Claims
0Family size

Inventors

Key dates

Filing dateAug 31, 2007
Grant dateOct 12, 2010
Priority date
Expiry dateOct 29, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Mammalian GLP-2 mimetibodies, polypeptides and nucleic acids are disclosed. Methods of utilizing the mimetibodies and polypeptides to treat GLP-2 related diseases are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.